Clinical and Radiographic Outcomes After AMIC Treatment for Talus Osteochondral Lesion Trattamento Artroscopico Delle Lesioni Osteocondrali Dell'Astragalo Con Tecnica AMIC
NCT ID: NCT03371121
Last Updated: 2017-12-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
103 participants
INTERVENTIONAL
2016-04-26
2028-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
AMIC vs. MFx in the Ankle
NCT05741983
Relevance of Osteochondral Lesions in Ankle Microinstability
NCT06947317
An Observational, Prospective Study of Patients With Chondral and/or Osteochondral Defects of the Knee Treated With NAMIC
NCT03625180
Microfracture With Platelet Rich Plasma Gel Injection for Osteochondral Lesion of the Talus
NCT06358807
Augmentation of Meniscal Repair With Marrow Stimulation Techniques (Microfractures)
NCT02323490
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Chondro-gide - Geistlich
Arthroscopic use of chondro-gide to treat symptomatic osteochondral talar lesion
AT-AMIC (arthroscopic talus autologous matrix induced chondrogenesis)
to fill arthroscopically osteochondral talar lesion
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
AT-AMIC (arthroscopic talus autologous matrix induced chondrogenesis)
to fill arthroscopically osteochondral talar lesion
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* males and females
* patients underwent arthroscopic cartilage reconstruction surgery with AMIC technique for osteochondral lesions of the talus
Exclusion Criteria
* patients with previous surgery on the affected ankle
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Federico G Usuelli, MD
Role: PRINCIPAL_INVESTIGATOR
IRCCS Istituto Ortopedico Galeazzi
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Federico Usuelli
Milan, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AMIC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.